Treatment of STEMI with neither PCI nor thrombolysis
A previously healthy 63-year-old patient was admitted to our hospital with typical chest pain after hard work in the forest. He was treated by an emergency doctor with 5000 U…
Statin improves outcome of patients presenting with first acute myocardial infarction
Background Use of statin after an acute myocardial infarction (AMI) improves outcomes. However, it is debated whether receiving statin for primary prevention improves in-hospital outcomes when presenting with the first…
Impact of culprit vessel location in acute myocardial infarction on clinical outcome
Background Patients presenting with ST-elevation myocardial infarction (STEMI) have different clinical outcomes based on their clinical baseline characteristics and presentation. This study was aimed to determine the importance of lesion…
Combined intracoronary tirofiban and manual thrombectomy during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
Background This study assessed the probable synergistic effect of combination of intracoronary (IC) tirofiban and manual thrombectomy (MT) during primary percutaneous coronary intervention (pPCI) in patients with acute ST-elevation myocardial…
Laser and localized IIb/IIIa inhibitor via the ClearWay infusion catheter in AMI
The treatment of STEMI using balloon angioplasty and stent is problematic because of potential distal embolization, microvascular plugging, decreased myocardial perfusion and higher mortality. Excimer laser coronary atherectomy (ELCA) can…
Does the smoker’s paradox still exist in the clopidogrel and DES era?
Background Prior studies have found an apparent paradox: the acute phase outcomes in smokers after acute myocardial infarction (MI) are superior to those of nonsmokers. Further, smoking is reported to…
Cardiogenic shock and STEMI requiring circulatory assist device. result of a French Brittany prospective registry about 2700 patients (ORBI)
Purpose Recent improvement in management of ST-elevation myocardial infarction (STEMI), and notably reduction of delays to coronary reperfusion, allowed a decrease of the incidence of complications. This study aims at…
Results of PCI on nonculprit lesion in acute myocardial infarction: result of a French Brittany prospective registry about 2700 patients (ORBI)
Purpose For patients (pts) who present an acute myocardial infarction (STEMI), the benefit of PCI in culprit lesion is clearly demonstrated. Regarding this population, around 40% of pts had multivessel…
Incidence of left ventricular thrombus formation in the modern era of primary percutaneous coronary intervention
Background Left ventricular thrombus formation is a recognized complication of ST-elevation myocardial infarction (STEMI). Little information exists about the incidence of LV thrombus formation in the modern era of primary…
Impact of intracoronary administration of nitroprusside vs. nitroglycerine before balloon dilatation on slow reflow during percutaneous coronary intervention in patients with acute ST elevation myocardial infarction
Background Retrospective data have shown that selective intracoronary administration of nitroprusside prior to percutaneous coronary intervention (PCI) is safe, prevents no or slow reflows and improves reperfusion of the infarcted…
